Thursday, 6 August 2015

EFIB 2015: Is the Chemical Industry catching up with Biobased?

The European Forum for Industrial Biotechnology and the Bioeconomy (EFIB) is the market leading annual event in Europe for Industrial Biotechnology and the Bioeconomy. And the 2015 event on 27-29 October promises to be better than ever. The eighth EFIB takes place at The Square in Brussels and will welcome some 90 industry experts and over 700 delegates from the leading sectors in biobased value chains and address the future of the bioeconomy in Europe. SusChem and Cefic are organising a dedicated session on biobased chemical value chains as part of EFIB2015.

Industrial Biotechnology is currently worth €23 billion – this represents just 6% of sales in the overall worldwide chemicals market. However, the sector is significantly out-performing the overall chemicals market at an impressive 20% annual growth rate. and it has the potential to become the dominant technology of tomorrow’s chemicals industry representing a huge future opportunity.

Delivering on this opportunity will require significant investment, innovation and value chain development and, most importantly, new collaborations across the sector. In addition the chemical industry is faced with important challenges posed by high energy prices, the impact of the shale gas boom on the development of biobased chemicals markets and the ongoing need for predictable, coherent and supportive policy in the EU.

A biobased Chemical Industry?
In order to understand and overcome these challenges and prosper in the industrial biotechnology market, industry experts throughout the vibrant and innovative biobased community are coming together to discuss the key issues at EFIB2015.

The Cefic session at EFIB2015 takes place on the morning of 29 October and will be chaired and introduced by Pierre Barthélemy, Executive Director Research and Innovation at Cefic. The view of the European Commission DG GROW will be given by Reinhard Buescher, Head of Unit for Chemicals Industry.

Insights from industry will be presented by François Monnet from Solvay,  Dr. Henrike Gebhardt of Evonik Industries AG, Dr. Stefan Lundmark of Perstorp AB, and Dr Marcel Wubbolts from DSM. The presentations will be followed by a group discussion.

SusChem and the bioeconomy
The SusChem Strategic Innovation and Research Agenda (SIRA) has a dedicated chapter on ‘A Sustainable and Inclusive Bioeconomy’ and SusChem is an essential link between the chemical industry, industrial biotechnology and stakeholders in the bioeconomy.

The platform is actively involved in two large and relevant PPPs between the European Commission and industry launched in 2014:
SusChem contributes to the alignment of both initiatives. The interface between BBI and SPIRE is the provision and use of biobased platform chemicals. In addition, both PPPs may support projects using biotechnological conversion processes and specific improvements of biotechnology processes may be eligible for funding through either PPP. SusChem will enable the coherence of ongoing and future funding initiatives and the deployment of flagship projects that demonstrate technological leadership and that Europe is a globally competitive location to invest in the bioeconomy.

More information on EFIB
Delegates to EFIB2015 will receive a comprehensive update on the status and outlook for the biobased industries in Europe and globally. EFIB is proud to foster engagement between policy makers, a broad range of stakeholders connected with the existing biobased value chain and seeks to reach out to, and include, new interlocutors. EFIB2015 is the only meeting to combine high-level discussions on business and policymaking.

If you book by 8 August you can save € 300 on your registration.

The conference kicks off with a set of pre-conference Workshops on 27 October with the full conference on 28 October and 29 October. You can request a full conference brochure here.

No comments:

Post a Comment

Please post your comment here. Please note that this newsblog is not moderated.